Better access to healthcare equals better health outcomes. Biogen strives to increase access and address the barriers that patient populations face. Oftentimes, health outcomes...
The devastating impact of the COVID-19 pandemic, particularly on communities of color, has been a painful reminder of the racial and ethnic disparities that...
By: Luther T. Clark, MD, Deputy Chief Patient Officer, Merck
Barriers to participation of racially and ethnically underrepresented patients in clinical trials include: (1) mistrust,...
Shauna Whisenton was once an individual living with sickle cell disease (SCD). Now she’s an advocate for better therapies, a cure, and better understanding...
The importance of clinical research is widely recognized and while many decide to participate in clinical trials, there is a lack of representation of...
